MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc. is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Pharmaceutical Preparations.
The next scheduled catalyst is A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC on July 31, 2027. There are 2 upcoming events on record.
| Date | Event | Type | Phase |
|---|---|---|---|
| July 31, 2027 | A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC | Trial Milestone | Phase 3 |
| September 30, 2027 | THIO Sequenced With Cemiplimab in Advanced NSCLC | Trial Milestone | Phase 2 |
Track MAIA alongside other companies. Add it to a watchlist and see every catalyst on one calendar.
Open MAIA in the tracker| Date | Event | Type | Phase |
|---|---|---|---|
| October 6, 2026 | 8-K filed: Reg FD disclosure | Filing | — |
| April 16, 2026 | 8-K filed: Other event | Filing | — |
| April 8, 2026 | 8-K filed: Other event | Filing | — |
| April 2, 2026 | 8-K filed: Leadership change | Corporate | — |
| March 31, 2026 | 8-K filed: Other event | Filing | — |
| March 27, 2026 | 8-K filed: Reg FD disclosure, Other event | Filing | — |
| March 4, 2026 | 8-K filed: Material agreement, Other event | Corporate | — |
| February 24, 2026 | 8-K filed: Other event | Filing | — |
| January 20, 2026 | 8-K filed: Other event | Filing | — |
| January 13, 2026 | 8-K filed: Reg FD disclosure, Other event | Filing | — |
| December 17, 2025 | 8-K filed: Material agreement, Other event | Corporate | — |
| December 11, 2025 | 8-K filed: Other event | Filing | — |
| December 10, 2025 | 8-K filed: Other event | Filing | — |
| November 21, 2025 | 8-K filed: Other event | Filing | — |
| November 20, 2025 | 8-K filed: Other event | Filing | — |
| November 7, 2025 | 8-K filed: Other event | Filing | — |
| October 27, 2025 | 8-K filed: Other event | Filing | — |
| October 24, 2025 | 8-K filed: Other event | Filing | — |
| October 23, 2025 | 8-K filed: Reg FD disclosure, Other event | Filing | — |
| October 14, 2025 | 8-K filed: Material agreement, Other event | Corporate | — |
| October 7, 2025 | 8-K filed: Other event | Filing | — |
| September 30, 2025 | 8-K filed: Material agreement, Other event | Corporate | — |
| September 24, 2025 | 8-K filed: Other event | Filing | — |
| September 18, 2025 | 8-K filed: Material agreement | Corporate | — |
| September 12, 2025 | 8-K filed: Other event | Filing | — |
| September 11, 2025 | 8-K filed: Other event | Filing | — |
| September 8, 2025 | 8-K filed: Reg FD disclosure, Other event | Filing | — |
| August 13, 2025 | 8-K filed: Other event | Filing | — |
| July 28, 2025 | 8-K filed: Other event | Filing | — |
| July 17, 2025 | 8-K filed: Other event | Filing | — |
Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.
Last updated 2026-10-14.